XML 26 R13.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Non-Current Assets
3 Months Ended
Mar. 31, 2024
Non-Current Assets  
Non-Current Assets

6.            Non-Current Assets

As of March 31, 2024, the Company had non-current assets of $1.2 million, which comprised of clinical trial deposits held by a contract research organization in relation to the Company’s Phase 1/2 clinical trials.